Regarding CD39+ T-regs cells, COVID-19 patients had considerably greater frequencies of CD39+ T-regs compared to controls (47 ± 2.7 vs. 29 ± 4.2; p = 0.003). Here, ENTPD1 is linked to COVID-19.